Type of information: Company acquisition
Acquired company: GATC Biotech (Germany)
Acquiring company: Eurofins Scientific (Luxembourg)
- • On June 2, 2017, Eurofins Scientific, a global leader in bio-analytical testing, announced that it has signed an agreement to acquire GATC Biotech , one of Europe’s specialists in DNA sequencing. The transaction is expected to close in July, subject to the fulfilment of customary closing conditions. The acquisition should therefore further reinforce Eurofins' footprint in DNA sequencing, and strengthen the Group's technological platform supporting its genetic testing innovations.
- Founded in 1990, GATC has achieved a strong recognition for DNA and RNA sequencing, as well as bioinformatics in Europe. The company employs 140 staff across 2 sites, and serves over 10,000 institutional and academic customers, generating annual revenues of about € 20m. As one of the larger players in Custom and Next Generation Sequencing, GATC has built a reputation for innovative, internally-developed applications, as well as industry-leading turn-around time (TAT).
Related: Technology - Services